Who is the Top Investor In Transmedics Group Inc (TMDX)?

Transmedics Group Inc (NASDAQ: TMDX) is 3.89% higher on its value in year-to-date trading and has touched a low of $36.42 and a high of $99.63 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TMDX stock was last observed hovering at around $88.71 in the last trading session, with the day’s loss setting it -6.71%.

Currently trading at $82.00, the stock is -5.81% and -1.44% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.37 million and changing -7.56% at the moment leaves the stock 14.36% off its SMA200. TMDX registered 5.18% gain for a year compared to 6-month gain of 34.25%. The firm has a 50-day simple moving average (SMA 50) of $11.58 and a 200-day simple moving average (SMA200) of -$176.21.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -7.53% loss in the last 1 month and extending the period to 3 months gives it a 16.64%, and is -5.74% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.55% over the week and 4.95% over the month.

Transmedics Group Inc (TMDX) has around 584 employees, a market worth around $2.68B and $241.62M in sales. Fwd P/E is 185.66. Profit margin for the company is -10.36%. Distance from 52-week low is 125.15% and -17.70% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.84%).

Transmedics Group Inc quarterly earnings per share for the current quarter are estimated at -$0.13 with sales reaching $83.9M over the same period.The EPS is expected to grow by 94.13% this year, but quarterly earnings will post 51.90% year-over-year. Quarterly sales are estimated to grow 101.90% in year-over-year returns.

347 institutions hold shares in Transmedics Group Inc (TMDX), with institutional investors hold 115.30% of the company’s shares. The shares outstanding are 32.67M, and float is at 31.46M with Short Float at 15.67%. Institutions hold 111.34% of the Float.

The top institutional shareholder in the company is FMR, LLC with over 3.31 million shares valued at $277.78 million. The investor’s holdings represent 10.15% of the TMDX Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 2.31 million shares valued at $193.94 million to account for 7.08% of the shares outstanding. The other top investors are Lord, Abbett & Co. LLC which holds 1.87 million shares representing 5.74% and valued at over $157.02 million, while Vanguard Group Inc holds 5.47% of the shares totaling 1.78 million with a market value of $149.87 million.

Transmedics Group Inc (TMDX) Insider Activity

A total of 11 insider transactions have happened at Transmedics Group Inc (TMDX) in the last six months, with sales accounting for 7 and purchases happening 4 times. The most recent transaction is an insider sale by Khayal Tamer I, the company’s Chief Commercial Officer. SEC filings show that Khayal Tamer I sold 250 shares of the company’s common stock on Feb 20 at a price of $90.00 per share for a total of $22500.0. Following the sale, the insider now owns 14375.0 shares.

Transmedics Group Inc disclosed in a document filed with the SEC on Feb 16 that Khayal Tamer I (Chief Commercial Officer) sold a total of 2,858 shares of the company’s common stock. The trade occurred on Feb 16 and was made at $90.00 per share for $0.26 million. Following the transaction, the insider now directly holds 14375.0 shares of the TMDX stock.

Still, SEC filings show that on Feb 15, Khayal Tamer I (Chief Commercial Officer) disposed off 776 shares at an average price of $90.00 for $69840.0. The insider now directly holds 14,375 shares of Transmedics Group Inc (TMDX).